Caxton Associates (New York)’s Pacira BioSciences PCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-34,200	Closed	-$515K	–	629
2024 Q3	$515K	Buy	+34,200	New	+$515K	0.02%	357
2020 Q3	–	Sell	-4,866	Closed	-$255K	–	452
2020 Q2	$255K	Buy	+4,866	New	+$255K	0.02%	293